TABLE 3.
Antagonist aname | Ki nM | Indications | References |
---|---|---|---|
Theophylline | 1710 | Fredholm et al. (2011) | |
Caffeine | 9,560–23,400 | Fredholm et al. (2011) | |
Istradefylline | 2–91 | M. Parkinson | Fredholm et al. (2011), Cacciari et al. (2018) |
Tozadenant | 5 | M. Parkinson | Cacciari et al. (2018) |
ZM 241385 | 0.8 | Cacciari et al. (2018) | |
MSX-2 | 5–8.0 | Fredholm et al. (2011), Cacciari et al. (2018) | |
SCH 58261 | 1.1–5 | Fredholm et al. (2011), Cacciari et al. (2018) | |
SCH 442416 | 0.048–4.1 | Fredholm et al. (2011), Cacciari et al. (2018) | |
Preladenant | 0.9–1.1 | M. Parkinson | Fredholm et al. (2011), Cacciari et al. (2018) |
Vipadenant | 1.3 | M. Parkinson | Cacciari et al. (2018) |
ST 1535 | 6.6–11 | Fredholm et al. (2011), Cacciari et al. (2018) | |
ST 4206 | 9 | Cacciari et al. (2018) | |
CGS 15943 | 1.2 | Fredholm et al. (2011) | |
CSC | 54 | Fredholm et al. (2011) | |
V2006 | 1.3 | Fredholm et al. (2011) |
The range of Ki values is probably due to species differences and small difference in methodology.